Etanercept Completed Phase 2 Trials for Histiocytosis, Langerhans-Cell Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00048373Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL